Viewing Study NCT05303467


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-02-02 @ 7:50 PM
Study NCT ID: NCT05303467
Status: RECRUITING
Last Update Posted: 2025-11-28
First Post: 2022-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Sponsor: Boston Scientific Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma Multiforme View
None Recurrent Glioblastoma View
Keywords: